Screener
CytomX Therapeutics CTMX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's operating lease ROU assets?
- CytomX Therapeutics (CTMX) reported operating lease ROU assets of $5.04M in Q2 2026.
- How has CytomX Therapeutics's operating lease ROU assets changed year-over-year?
- CytomX Therapeutics's operating lease ROU assets decreased by 15.3% year-over-year, from $5.95M to $5.04M.
- What is the long-term trend for CytomX Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), CytomX Therapeutics's operating lease ROU assets has grown at a -31.5% compound annual growth rate (CAGR), from $22.5M to $3.4M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about CytomX Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude